Dr. Johan Malmström Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden – Brånemark Clinic Gothenburg, Sweden, Dr. Jonas Anderud Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden
A new study from researchers at the University of Pittsburgh seeks to yield a more detailed and holistic picture of temporomandibular disorder than ever before. (Image: muhamed/Adobe Stock)
PITTSBURGH, US: A new US$17 million research initiative led by the University of Pittsburgh is set to revolutionise understanding and treatment of temporomandibular disorder (TMD). Funded by the US National Institute of Dental and Craniofacial Research, the five-year project—the Collaborative for Research to Advance TMD Evidence—is the largest coordinated effort yet to study chronic TMD-related pain.
Dr Alejandro Almarza and Dr Michael Gold of the University of Pittsburgh. (Image: Rayni Shiring)
Despite decades of research, the mechanisms underlying TMD-related pain remain elusive, and treatment outcomes are often inconsistent. As Dental Tribune International has reported, recent research into TMD has shown that it affects women more than men and may be increasing in prevalence. Investigating its aetiology is thus a highly timely undertaking.
The University of Pittsburgh project is being led by Dr Alejandro Almarza, associate professor of oral and craniofacial sciences at the university’s dental school, and Dr Michael Gold, professor of neurobiology at the medical school. It will collect and analyse an extensive range of biological, neurological and psychosocial data from 1,000 individuals with TMD and 300 pain-free controls across five national research sites. This will involve brain imaging, RNA sequencing, epigenomic and proteomic profiling, and microbiome analysis, offering unprecedented insight into the complex mechanisms of chronic jaw pain.
Speaking about the research in a university press release, Dr Almarza said: “It’s the first time that we’ll be able to recruit this many patients with TMDs and try to understand their pain condition.” Prof. Gold explained that the project takes “an integrated, whole-person view of the problem, and that adds complexity, both in the factors influencing the manifestation of the pain syndrome but also in its management”.
The research will build on earlier work from the landmark Orofacial Pain Prospective Evaluation and Risk Assessment study, extending the focus from identifying who develops TMD to understanding the nature and persistence of ongoing pain. The data collected will support detailed patient phenotyping, helping to identify biomarkers that can guide precision treatment approaches and improve outcomes.
By refining preclinical models and establishing causal links between biological and environmental factors, the study aims to develop more effective, personalised therapies. The collaborative approach is essential given the relative rarity and diversity of TMD conditions. The project also emphasises education and training and will integrate dental and medical students in hands-on research and curriculum development to embed new findings into clinical practice.
UMEÅ, Sweden: Orofacial pain, including pain associated with temporomandibular disorder (TMD), is a common chronic condition, affecting 10%–15% of the ...
STOCKHOLM, Sweden: A recent public health study in Sweden has revealed an intriguing and important phenomenon: temporomandibular disorder in the country is ...
When there is alteration of any of the internal structures that make up the temporomandibular joint (TMJ), it can be said that we are facing possible ...
OSLO, Norway: Temporomandibular disorder (TMD) pain afflicts younger people more disproportionally than adults, and up to 28% of children globally have ...
Education
Live webinar Tue. 21 October 2025 3:00 PM EST (New York)
Dr. Johan Malmström Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden – Brånemark Clinic Gothenburg, Sweden, Dr. Jonas Anderud Department of Oral and Maxillofacial Surgery, Halmstad, Sweden – Department of Biomaterials, Gothenburg University, Sweden
BOSTON, US: In the US, dental care remains largely excluded from medical insurance and separated from public health initiatives that promote prevention. A ...
FORT LAUDERDALE, Fla., US: Swiss dental implant specialist Patent Medical has been named “Dental Implants Manufacturer of the Year in Europe” by MedTech...
To post a reply please login or register